Institutional shares held 103 Million
0 calls
277K puts
Total value of holdings $2.11B
$0 calls
$5.69M puts
Market Cap $2.11B
102,820,000 Shares Out.
Institutional ownership 99.94%
# of Institutions 386


Latest Institutional Activity in CPRX

Top Purchases

Q3 2025
Wedge Capital Management L L P Shares Held: 145K ($2.98M)
Q3 2025
Voya Investment Management LLC Shares Held: 446K ($9.16M)
Q3 2025
Exchange Traded Concepts, LLC Shares Held: 63K ($1.29M)
Q3 2025
Assenagon Asset Management S.A. Shares Held: 144K ($2.96M)
Q3 2025
City Center Advisors, LLC Shares Held: 12.9K ($264K)

Top Sells

Q3 2025
Toth Financial Advisory Corp Shares Held: 2.15K ($44.1K)
Q3 2025
Richard P Slaughter Associates Inc Shares Held: 21K ($432K)
Q3 2025
Pacer Advisors, Inc. Shares Held: 621K ($12.7M)
Q3 2025
Juncture Wealth Strategies, LLC Shares Held: 83.4K ($1.71M)
Q3 2025
Yousif Capital Management, LLC Shares Held: 36.2K ($742K)

About CPRX

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.


Insider Transactions at CPRX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.62M Shares
From 14 Insiders
Exercise of conversion of derivative security 2.55M shares
Open market or private sale 70K shares
Sell / Disposition
1.99M Shares
From 15 Insiders
Payment of exercise price or tax liability 50.4K shares
Open market or private sale 1.94M shares

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX